跳至主要内容
临床试验/IRCT2015042020951N2
IRCT2015042020951N2已完成未知

The study of treatment of Helicobacter Pylori in improvement of non-alcoholic fatty liver disease

research department of medical college of QUMS0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Inclusion Criteria: Helicobacter Pylori Infection according to serologic test; Non-alcoholic fatty liver disease according to liver function tests and sonography; consent to participation in the study.
  • Exclusion criteria: presence of any other medical disease; history of hypersensitivity to the prescribed drugs; non-consent to the participation to the study

排除标准

  • 未提供

研究者

发起方
research department of medical college of QUMS

相似试验

招募中
不适用
Clinical investigation of Helicobacter pylori infection and eradication therapy.Patients who undergo EGD.
JPRN-UMIN000012036Tokyo medical5,000
已完成
不适用
Study of Helicobacter pylori eradication therapy using vonoprazaHelicobacter infection
JPRN-UMIN000019158Tsuyama Chuo Hospital2,000
已完成
不适用
Clinical study of combination of Helicobacter pylori eradication therapy and ingestion of bifidobacteria-fermented milkHelicobacter pylori infection
JPRN-UMIN000008834Medical Station Clinic Aisei Hospital, Ueno Clinic200
进行中(未招募)
1 期
Helicobacter pylori eradication with Probiotic Lactobacillus casei rhamnosus LCR35 Alone or in Combination with Antibiotic TherapyHelicobacter pylori infection
EUCTR2017-005111-14-ATKepler Universitätsklinikum, Medcampus III, Klinik für Interne 2440
进行中(未招募)
不适用
Treatment of Helicobacter pylori infection with high dose esomeprazole, amoxicillin and metronidazole in pediatric patients infected with double resistant Helicobacter pylori strains - HP-DR-STUDIESymptomatic, H. pylori-infected male and female patients <18 years of age with a positive culture of H. pylori and proven resistance to metronidazole & clarithromycin (E-test or agar diffusion). MIC (minimal inhibitory concentration) breakpoints for resistance are defined as follows: metronidazole >16 µg/mlclarithromycin >1.0 µg/mlamoxicillin > 0.5 µg/ml.
EUCTR2006-002639-26-DEKlinikum der Universität München, Kinderklinik und Poliklinik im Dr. von Haunersches Kinderspital